|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo; 2Institute of Medical Sciences, Tokai University, Kanagawa, Japan; and 3Division of Pediatric Nephrology, Massachusetts General Hospital, Boston, Massachusetts
Submitted 28 February 2005 ; accepted in final form 10 June 2005
Hypoxia-inducible factor (HIF)-1 is a transcription factor mediating cellular response to hypoxia. Although it is expressed in tubular cells of the ischemic kidney, its functional role is not fully clarified in the pathological context. In this study, we investigated a role of HIF in tubular cell apoptosis induced by cisplatin. HIF-1
was expressed in tubular cells in the outer medulla 3 days after cisplatin (6 mg/kg) administration. With the in vivo administration of cobalt to activate HIF, the number of apoptotic renal tubular cells became much smaller in the outer medulla, compared with the vehicle group. We also examined the functional role of HIF-1 in vitro using immortalized rat proximal tubular cells (IRPTC). In hypoxia, IRPTC that express dominant-negative (dn) HIF-1
showed impaired survival in cisplatin injury at variable doses (25100 µM, 24 h), which was not obvious in normoxia. The observed difference in cell viability in hypoxia was associated with the increased number of apoptotic cells in dnHIF-1
clones (Hoechst 33258 staining). Studies on intracellular signaling revealed that the degree of cytochrome c release, dissipation of mitochondrial membrane potentials, and caspase-9 activity were all more prominent in dnHIF-1
clones than in control IRPTC, pointing to the accelerated signaling of mitochondrial pathways. We propose that HIF-1 mediates cytoprotection against cisplatin injury in hypoxic renal tubular cells, by reducing the number of apoptotic cells through stabilization of mitochondrial membrane integrity and suppression of apoptosis signaling. A possibility was suggested that activation of HIF-1 could be a new promising therapeutic target for hypoxic renal diseases.
apoptosis; mitochondria; caspase
This article has been cited by other articles:
![]() |
E. H. Bae, J. Lee, S. K. Ma, I. J. Kim, J. Frokiaer, S. Nielsen, S. Y. Kim, and S. W. Kim {alpha}-Lipoic acid prevents cisplatin-induced acute kidney injury in rats Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2692 - 2700. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schodel, B. Klanke, A. Weidemann, B. Buchholz, W. Bernhardt, M. Bertog, K. Amann, C. Korbmacher, M. Wiesener, C. Warnecke, et al. HIF-Prolyl Hydroxylases in the Rat Kidney: Physiologic Expression Patterns and Regulation in Acute Kidney Injury Am. J. Pathol., May 1, 2009; 174(5): 1663 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ma, T. Lim, J. Xu, H. Tang, Y. Wan, H. Zhao, M. Hossain, P. H. Maxwell, and M. Maze Xenon Preconditioning Protects against Renal Ischemic-Reperfusion Injury via HIF-1{alpha} Activation J. Am. Soc. Nephrol., April 1, 2009; 20(4): 713 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohtomo, M. Nangaku, Y. Izuhara, S. Takizawa, C. v. Y. d. Strihou, and T. Miyata Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1166 - 1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Minamishima, J. Moslehi, N. Bardeesy, D. Cullen, R. T. Bronson, and W. G. Kaelin Jr Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure Blood, March 15, 2008; 111(6): 3236 - 3244. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Weidemann, W. M. Bernhardt, B. Klanke, C. Daniel, B. Buchholz, V. Campean, K. Amann, C. Warnecke, M. S. Wiesener, K.-U. Eckardt, et al. HIF Activation Protects From Acute Kidney Injury J. Am. Soc. Nephrol., March 1, 2008; 19(3): 486 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Ray, S. Arab, Y. Deng, P. Liu, L. Penn, D. W. Courtman, and M. E. Ward Oxygen regulation of arterial smooth muscle cell proliferation and survival Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H839 - H852. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhou, D. K. Ann, X. Li, K.-J. Kim, H. Lin, P. Minoo, E. D. Crandall, and Z. Borok Hypertonic induction of aquaporin-5: novel role of hypoxia-inducible factor-1{alpha} Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1280 - C1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tanaka, H. Kato, I. Kojima, T. Ohse, D. Son, T. Tawakami, T. Yatagawa, R. Inagi, T. Fujita, and M. Nangaku Hypoxia and expression of hypoxia-inducible factor in the aging kidney. J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2006; 61(8): 795 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. H. Haase Hypoxia-inducible factors in the kidney Am J Physiol Renal Physiol, August 1, 2006; 291(2): F271 - F281. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, M. P. Biju, M.-H. Wang, V. H. Haase, and Z. Dong Cytoprotective Effects of Hypoxia against Cisplatin-Induced Tubular Cell Apoptosis: Involvement of Mitochondrial Inhibition and p53 Suppression J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1875 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nangaku Chronic Hypoxia and Tubulointerstitial Injury: A Final Common Pathway to End-Stage Renal Failure J. Am. Soc. Nephrol., January 1, 2006; 17(1): 17 - 25. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |